Abstract: An analysis system for testing a biological sample wherein a sensor cover can be or is pneumatically lowered onto a sensor apparatus in order to detect an analyte of the sample.

Abstract: Packages that include at least one medicament therein include at least one light member affixed thereto that is capable of emitting light upon activation. The light member is activated upon the opening of the package such that, upon opening, the light member fluoresces or otherwise emits light to provide information to an end user. In some embodiments, the light generated by the light member allows the end user to locate the package in dark conditions. In other embodiments, the light generated by the light member may be configured to emit only for a time period equal to a viability time period of the medicament within the package or to change color at a time period equal to the viability time period of the medicament within the package to alert an end user that the medicament is no longer useable.

Abstract: An analysis device, a cartridge and a method for analysing a sample are provided, including a rotatable pump head having contact elements that are resiliently biased in the axial direction acting on an elastically deformable pump chamber in order to pump or convey a fluid, such as the sample, a reagent or a gas, when the pump head rotates, in particular in a defined and/or efficient manner.

Abstract: An analysis system and a method for testing a biological sample is provided, wherein the sensitivity of the evaluation electronics of a fluid sensor is specified and/or changed depending on a phase of the test sequence and/or a cartridge identifier of the cartridge, and/or in that the fluid sensor comprises a sensor electrode that is intended for measuring electrical capacitance and is operated in a manner in which it is electrically connected to the evaluation electronics by a single pole and/or by means of a shielded sensor line.

Abstract: A cartridge for testing a sample, in particular, a biological sample, and a method for the production of such a cartridge are provided, the cartridge comprising a main body having a plurality of channels and cavities that are covered by a cover or a film. For the purpose of simple production, liquid reagents are introduced into corresponding storage cavities through the main body, with the storage cavities being optionally (additionally) covered by aluminium film. Furthermore, a conditioned atmosphere is preferably introduced into a closed fluid system in the cartridge containing dry reagents and/or a sensor apparatus.

Abstract: Analysis systems and methods for testing a biological sample is provided, wherein the inclination is monitored and/or a light strip is provided as a display apparatus that signals an operating state or a requirement.

Abstract: A cartridge for analyzing a biological sample, wherein the cartridge includes a fluid system having a plurality of channels and at least one valve, wherein the valve is covered on the outside by a cover, and wherein the valve is configured to be actuated by deforming a wall of the valve.

Abstract: A cartridge, an analysis system, and a method for testing a sample, such as, environmental, food or biological sample, wherein the cartridge has two memory elements that are different and/or can be read out by different methods and which correspond to the cartridge or to the batch thereof.

Abstract: A sample is measured using a cartridge from a batch comprising a plurality of cartridges of the same type. The measurement results measured in the process are evaluated. In order to evaluate the measurement results, reference results are used in addition, which reference results were measured previously, separately, during measurements of reference samples, using a plurality of cartridges of the same batch. An analyte of the sample is determined from the measurement results. During the evaluation, the reference results and/or measurement results are preferably normalized.

Abstract: The invention is directed to a pharmaceutical tablet formulation for the veterinary medical sector containing an instable ACE inhibitor or a pharmaceutically acceptable salt thereof as a first pharmaceutically active substance, and pimobendan or a pharmaceutically acceptable salt thereof as a second pharmaceutically active substance, comprising granules which contain carrier core particles coated with at least one layer wherein the first pharmaceutically active substance is present, the granules being embedded in a tablet matrix wherein the second pharmaceutically active substance is present. It is provided a “fixed-dose-combination” which allows to ease the treatment and administration of the medication, improves the medication compliance by reducing the pill burden to the animal holder and enables the better observation of and adherence to the therapy by decreasing the number of tablets to be administered.

Abstract: A chip and a method for producing the chip with a plurality of measurement regions which are provided with electrodes for electrically detecting reactions in which, in order to reliably separate the individual measurement regions from one another, a monolayer of a fluorosilane is formed on the chip surface which has strongly hydrophobic properties. Therefore, during spotting with a liquid, the drops of liquid applied by spotting can be reliably prevented from coalescing, and thus, causing mixing of the substances in the drops of liquid which are supposed to be immobilized in the measurement regions.

Abstract: A cartridge and an analysis system for testing a sample, and, in particular, a biological sample are provided, wherein the cartridge includes a connection for a working medium and a planar seal in order to seal the connection while the working medium is being fed into a manipulating apparatus. In embodiments, the cartridge and analysis system includes a pump apparatus for conveying the sample, the pump apparatus including a pump chamber that is elastically deformable by means of a pump head.

Abstract: A method is described for the treatment of systemic diseases in cats. A composition is administered to a cat, where the composition includes a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan).

Abstract: A cartridge and a method for testing a biological sample are provided, wherein the cartridge is filled, in an open packaging, with the sample to be tested, and wherein the packaging holds and/or supports the cartridge in a latching manner in an open state.

Abstract: The invention relates to the field of medicine, in particular to the field of veterinary medicine. The invention specifically relates to muscarinic antagonists (including long acting muscarinic antagonists (LAMAs)) for the treatment of airway disease, such as pulmonary disease, preferably recurrent airway obstruction (RAO), summer pasture associated obstructive pulmonary disease (SPAOPD), and inflammatory airway disease (IAD) in animals, preferably equines such as horses.

Abstract: A cartridge, an analysis system, a method and a computer program product for testing a sample, such as, environmental, food or biological sample, wherein the cartridge has two memory means that are different and/or can be read out by different methods and which correspond to the cartridge or to the batch thereof.

Abstract: The present invention relates to the field of CAdV vector vaccines, and especially to promoters suitable to express target antigens from such vector vaccines. Disclosed and claimed are recombinant canine adenoviruses, methods of making them, uses for them (including in immunological, immunogenic, vaccine or therapeutic compositions, or, as a vector for cloning, replicating or expressing DNA and methods of using the compositions and vector), expression products from them, and uses for the expression products. Additionally, disclosed and claimed are truncated EHV4 promoters, expression cassettes containing the promoters, and recombinant viruses and plasmids containing the promoters or expression cassettes.

Abstract: A pharmaceutical solution with a pH value of 10 or higher contains an angiotensin II receptor antagonist, where one or more sugar alcohols are present up to a total concentration of 40 wt. % to 70 wt. %.

Abstract: Described herein is a solid tablet that is directly-compressed of powder, including meloxicam and one or more excipients which are homogenously dispersed within the tablet that can be broken into two, three or four units with each unit containing equal amounts of the active ingredient, meloxicam.

Abstract: The invention relates to the field of medicine, in particular to the field of veterinary medicine. The invention relates to glucocorticoids, especially ciclesonide or a pharmaceutically acceptable derivative or salt thereof, for the treatment of airway disease in horses, such as pulmonary disease, preferably recurrent airway obstruction (RAO), Summer Pasture Associated Obstructive Pulmonary disease (SPAOPD), and inflammatory airway disease (IAD).